Indeed, hypercholesterolemia and elevated TG have also been reported in LGMD type 1C [32] (caveolin-3 mutations) and myotonic dystrophies types 1 and 2 (DMPK and CNBP mutations, respectively) [33, 34] — although often in the absence of control conditions or using experimental approaches. This evidence concerns the gene CAV3 and familial hypercholesterolemia.